News
Worse outcomes for patients with COPD and COVID-19
- Author:
- Neil Osterweil
Worse outcomes include 14-day hospitalization, length of stay, ICU admission, 30-day mortality, and use of...
News
Sex differences in pediatric B-ALL outcomes persist
- Author:
- Neil Osterweil
Boys with B-lineage acute lymphoblastic leukemia continue to have slightly worse survival outcomes than girls...
News
Dr. Fauci: Extraordinary challenges, scientific triumphs with COVID-19
- Author:
- Neil Osterweil
“The speed and efficiency with which these highly efficacious vaccines were developed, and their potential for...
News
New guideline provides recommendations on reconstruction after skin cancer resection
- Author:
- Neil Osterweil
The multidisciplinary consensus guideline covers situations broadly applicable to the care of adults with fully resected skin cancer lesions.
News
Pediatric cancer survivors at risk for opioid misuse
- Author:
- Neil Osterweil
In the first year after the end of treatment, survivors of childhood cancers were at significantly greater risk...
News
No SPARKLE with ibrutinib plus chemo in r/r pediatric B-NHL
- Author:
- Neil Osterweil
Patients assigned to ibrutinib and chemotherapy had a higher proportion of prior rituximab exposure, a marker...
News
High MRD rates with CAR T in r/r B-ALL in kids
- Author:
- Neil Osterweil
Of 24 patients with relapsed/refractory disease, 16 went on to allogeneic stem cell transplant after responding to therapy with KTE-X19.
News
COVID-19 infection conveys imperfect immunity in young adults
- Author:
- Neil Osterweil
One in 10 Marine recruits with prior SARS-CoV-2 infections were reinfected during basic training.
News
Made-to-order TILs effective against metastatic melanoma
- Author:
- Neil Osterweil
Cell therapy with tumor-infiltrating lymphocytes extracted from tumor tissue yielded responses in patients with...
News
New combo shows benefit even in patients with high-risk HCC
- Author:
- Neil Osterweil
Updated data from the IMBRave150 trial show benefit for the combination of atezolizumab with bevacizumab even in...
News
New data dim hopes for ‘triumph of drug discovery’
- Author:
- Neil Osterweil
Excitement over novel drugs that showed efficacy against KRAS mutations has been muted somewhat by new data...
News
Deadly brain tumor: Survival extended by oncolytic virus product
- Author:
- Neil Osterweil
Improved survival was seen in a small trial in which a genetically engineered version of herpes simplex virus was infused directly into high-grade...
News
Presurgical nivo/chemo boosts pCR rates in NSCLC
- Author:
- Neil Osterweil
For patients with resectable non–small cell lung cancer, adding immunotherapy to platinum-based chemotherapy...
News
Combo shows efficacy in platinum-resistant ovarian cancer
- Author:
- Neil Osterweil
Ixabepilone plus bevacizumab improved outcomes, compared with ixabepilone alone.
News
Niraparib maintenance offers continued benefit in some with recurrent ovarian cancer
- Author:
- Neil Osterweil
Benefits were seen in patients with germline BRCA mutations.